Analysis of Risk Factors for High HIV Exposure in Neonates and Develop
|
This study investigates prenatal factors associated with
high-risk neonatal HIV exposure at delivery and constructs a nomogram
prediction model. |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...